Lisata Therapeutics, Inc. SEC filings LSTA

Lisata Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to May 17, 2011. Its latest annual report, Form ARS, was filed on Oct 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (officer or director change). The company's fiscal year ends on December 31.

Lisata Therapeutics, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Jan 8, 2026 —
424B5 Prospectus supplement Aug 21, 2024 —
S-8 Employee stock plan registration Jul 15, 2024 —
S-3 Shelf registration May 1, 2024 —
S-8 Employee stock plan registration Jul 13, 2023 —
S-8 Employee stock plan registration Oct 17, 2022 —
424B5 Prospectus supplement Sep 26, 2022 —
424B3 Prospectus Jul 29, 2022 —
S-4/A Filing Jul 26, 2022 —
S-4 Registration for a merger or exchange Jun 15, 2022 —
S-8 Employee stock plan registration Jun 30, 2021 —
424B5 Prospectus supplement Jun 4, 2021 —
424B2 Prospectus May 6, 2021 —
S-3 Shelf registration Apr 1, 2021 —
424B5 Prospectus supplement Feb 16, 2021 —
424B5 Prospectus supplement Feb 16, 2021 —
424B5 Prospectus supplement Feb 12, 2021 —
424B3 Prospectus Feb 5, 2021 —
S-3 Shelf registration Jan 29, 2021 —
424B3 Prospectus Sep 2, 2020 —
S-8 Employee stock plan registration Aug 18, 2020 —
S-3 Shelf registration Aug 18, 2020 —
424B3 Prospectus Jun 29, 2020 —
S-1 Registration statement Jun 19, 2020 —
424B5 Prospectus supplement May 26, 2020 —
424B5 Prospectus supplement Apr 27, 2020 —
424B5 Prospectus supplement Mar 20, 2019 —
424B5 Prospectus supplement Mar 14, 2019 —
424B5 Prospectus supplement Aug 2, 2018 —
424B2 Prospectus Aug 2, 2018 —
S-3 Shelf registration Jul 24, 2018 —
S-8 Employee stock plan registration Jun 20, 2018 —
S-8 Employee stock plan registration Jun 20, 2018 —
424B5 Prospectus supplement Feb 8, 2018 —
S-8 Employee stock plan registration Jan 4, 2018 —
424B3 Prospectus Sep 20, 2017 —
S-3/A S-3/a september 13, 2017 Sep 13, 2017 —
S-3 Shelf registration Sep 6, 2017 —
S-8 Employee stock plan registration Jun 9, 2017 —
S-8 Employee stock plan registration Jan 6, 2017 —
424B3 Prospectus Dec 19, 2016 —
S-3 Shelf registration Nov 15, 2016 —
424B5 Prospectus supplement Sep 15, 2016 —
S-8 Employee stock plan registration Jun 23, 2016 —
424B3 Prospectus Jun 7, 2016 —
S-3 Shelf registration Apr 8, 2016 —
424B5 Prospectus supplement Nov 5, 2015 —
S-3 Shelf registration Aug 6, 2015 —
S-8 Employee stock plan registration Jul 15, 2015 —
424B2 Prospectus May 28, 2015 —
FWP Free writing prospectus May 27, 2015 —
424B5 Prospectus supplement May 27, 2015 —
424B5 Prospectus supplement May 6, 2015 —
S-3 Shelf registration Jun 12, 2014 —
424B5 Prospectus supplement Jun 3, 2014 —
S-8 Employee stock plan registration Oct 4, 2013 —
424B2 Prospectus Oct 4, 2013 —
424B5 Prospectus supplement Oct 3, 2013 —
S-3 Shelf registration May 9, 2013 —
424B2 Prospectus Apr 30, 2013 —
424B5 Prospectus supplement Apr 29, 2013 —
S-3 Shelf registration Dec 7, 2012 —
S-8 Employee stock plan registration Nov 13, 2012 —
S-8 POS Filing Nov 13, 2012 —
S-8 POS Filing Nov 13, 2012 —
POS AM Filing Sep 17, 2012 —
S-3/A Filing Aug 24, 2012 —
S-3 Shelf registration Aug 24, 2012 —
S-3 Shelf registration Aug 24, 2012 —
424B3 Prospectus Aug 24, 2012 —
S-8 Employee stock plan registration May 11, 2012 —
S-8 POS Filing May 11, 2012 —
424B5 Prospectus supplement Mar 29, 2012 —
424B5 Prospectus supplement Mar 29, 2012 —
424B5 Prospectus supplement Sep 30, 2011 —
424B3 Prospectus Sep 16, 2011 —
S-3/A Form s-3/a Sep 16, 2011 —
S-4 Registration for a merger or exchange Sep 2, 2011 —
424B5 Prospectus supplement Jul 20, 2011 —
424B5 Prospectus supplement Jul 18, 2011 —

Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LSTA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Basking Ridge, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
320017
Former names
Caladrius Biosciences, Inc. (until Sep 15, 2022); CALADRIUS BIOSCIENCES, INC. (until Sep 15, 2022); NeoStem, Inc. (until Jun 5, 2015); PHASE III MEDICAL INC/DE (until Sep 1, 2006); CORNICHE GROUP INC /DE (until Aug 14, 2003)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.